PxRadia pxradia.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

PxRadia was formed in 2010 by Dr. Charles Morgan, a founder of multiple companies and a pioneer in monoclonal antibody development, with an exclusive license from Memorial Sloan-Kettering Cancer Center to commercialize the breakthrough research of Dr. Richard N. Kolesnick on the role of ceramide, a lipid, in cell signaling and cell death. PxRadia's therapy relies on a well vetted monoclonal antibody approach. Its bioactive, anti-lipid antibody can be used as a single-chain Fv form making it extr...Show all

PxRadia was formed in 2010 by Dr. Charles Morgan, a founder of multiple companies and a pioneer in monoclonal antibody development, with an exclusive license from Memorial Sloan-Kettering Cancer Center to commercialize the breakthrough research of Dr...Show all

Company (Alive / Active)

Phone: 480-652-4688

Fax:

8 Daybreak Lane

Savannah, 31411
Georgia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PxRadia $0.1M Apr 4, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PxRadia Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)